Alan Bryce discusses PT-112, a platinum-containing drug with immunogenic cell death mechanism and osteotropic properties, with Oliver Sartor. The phase-two dose-finding study enrolled heavily ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback